Association Between Human Immunodeficiency Virus (HIV) Infection and Male Hypogonadism

ConditionHypogonadism; Ovarian

Trial statusRecruiting

Trial phaseNot listed

Trial typeObservational

Biological sexMale

Age20+

SponsorNational Taiwan University Hospital

About this trial

Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population

Eligibility criteria

This trial accepts healthy volunteers

Qualifiers

HIV-infected men who have sex with men

HIV non-infected men

Disqualifiers

Use of testosterone supplement, anabolic steroid in the past one year.

History of pituitary , adrenal or gonad diseases

History of pituitary surgery or radiation therapy

History of systemic chemotherapy

Trial population

Cross-sectional study investigating the prevalence of hypogonadism in HIV-infected MSM population. Age-matched non-HIV infected group will be used as comparison group

Trial design

Design model

Cohort

Time perspective

Cross-sectional

Treatments tested in this trial

Testosterone
Diagnostic test
Serum total testosterone and free testosterone level

Treatment groups

1,200 Participants

are divided into 2 treatment groups

Group A: Case group1 intervention

Group B: Control group1 intervention

Trial outcomes

Primary outcomes

Symptoms of androgen deficiency

We use the score of Androgen Deficiency in Aging Males (ADAM) questionnaire to study the prevalence of hypogonadism in HIV-infected MSM population

Time frame

2021-2030

Serum free testosterone

We use serum free testosterone to study the prevalence of hypogonadism in HIV-infected MSM population

Time frame

2021-2030

Sponsors and contacts

Click on the lead sponsor to view all of their trials.

National Taiwan University Hospital

Lead sponsor

Source ClinicalTrials.gov

Apply now